TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29462094

Group type: EXPERIMENTAL
Intervention: Abaloparatide
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 26920966

Group type: EXPERIMENTAL
Intervention: Gelatine matrix with human thrombin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional surgical methods
Number of subjects: 60
Study: 24468860

Group type: EXPERIMENTAL
Intervention: Mechanical recanalization
Number of subjects: 25
Study: 22676931

Group type: EXPERIMENTAL
Intervention: 4% articaine with epinephrine (1:100,000)
Number of subjects: 88

Group type: COMPARATOR
Intervention: 4% articaine without epinephrine
Number of subjects: 88
Study: 21034891

Group type: EXPERIMENTAL
Intervention: Uncovered SEMS
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Partially covered SEMS
Number of subjects: 129
Study: 17435402

Group type: EXPERIMENTAL
Intervention: Error Reporting Promoting Program (ERPP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Ordinary error-reporting method (Control)
Number of subjects: 26
Study: 16285195

Group type: EXPERIMENTAL
Intervention: Active drug treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 12811943

Group type: EXPERIMENTAL
Intervention: Total Hip Replacement (THR)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Internal Fixation (IF)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Protein-rich liquid supplementation with anabolic steroid
Number of subjects: 100

Group type: COMPARATOR
Intervention: Undisplaced fractures
Number of subjects: 100

Group type: COMPARATOR
Intervention: Displaced fractures
Number of subjects: 100
Study: 11040889

Group type: EXPERIMENTAL
Intervention: Inpatient detoxification
Number of subjects: 0

Group type: COMPARATOR
Intervention: Out-patient treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Specialist inpatient setting
Number of subjects: 0

Group type: COMPARATOR
Intervention: General psychiatry inpatient setting
Number of subjects: 0
Study: 8713559

Group type: EXPERIMENTAL
Intervention: Maximal electrical stimulation (MES) for 1 to 2 months
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Maximal electrical stimulation (MES)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Anal plug (control group) for 1 month
Number of subjects: 73
Study: 1992876

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 6611964

Group type: EXPERIMENTAL
Intervention: 15-methyl PGF2 alpha with indomethacin suppositories before and during PG induction
Number of subjects: 30

Group type: COMPARATOR
Intervention: 15-methyl PGF2 alpha only
Number of subjects: 30
Study: 31486297

Group type: EXPERIMENTAL
Intervention: Weight Regainers (WR) (n=36)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Weight Maintainers (WM) (n=41)
Number of subjects: 77
Study: 29939879

Group type: EXPERIMENTAL
Intervention: Dynamic hyperinflation group
Number of subjects: 2575

Group type: COMPARATOR
Intervention: Normal VE curve group
Number of subjects: 2575

Group type: COMPARATOR
Intervention: Healthy persons
Number of subjects: 2575
Study: 26913636

Group type: EXPERIMENTAL
Intervention: Overweight children (BMI ≥ 85th percentile)
Number of subjects: 5532

Group type: COMPARATOR
Intervention: Nonoverweight children
Number of subjects: 5532

Group type: EXPERIMENTAL
Intervention: Children with metabolic abnormalities (younger group)
Number of subjects: 5532

Group type: EXPERIMENTAL
Intervention: Children with highest quartile of BMI
Number of subjects: 5532

Group type: EXPERIMENTAL
Intervention: Children with highest quartile of 2-hour glucose
Number of subjects: 5532

Group type: EXPERIMENTAL
Intervention: Blood pressure and cholesterol
Number of subjects: 5532
Study: 24911423

Group type: EXPERIMENTAL
Intervention: Telephone-delivered cognitive behavioral therapy (CBT) intervention for 8 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 80
Study: 22891799

Group type: EXPERIMENTAL
Intervention: High-Intensity Training (HI)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Low-Intensity Training (LI)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control
Number of subjects: 22
Study: 19711113

Group type: EXPERIMENTAL
Intervention: Natalizumab treatment for 12 months
Number of subjects: 384
Study: 16984937

Group type: EXPERIMENTAL
Intervention: SASP
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 15762946

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention (Group B)
Number of subjects: 4441

Group type: COMPARATOR
Intervention: Comparison group (Group A)
Number of subjects: 4441

Group type: EXPERIMENTAL
Intervention: Less comprehensive intervention (Group C)
Number of subjects: 4441

Group type: EXPERIMENTAL
Intervention: Less comprehensive intervention (Group D)
Number of subjects: 4441
Study: 12127707

Group type: EXPERIMENTAL
Intervention: Lomefloxacin (LOMX) 400 mg once daily
Number of subjects: 182

Group type: COMPARATOR
Intervention: Ciprofloxacin (CIPX) 500 mg twice daily
Number of subjects: 182
Study: 9771414

Group type: EXPERIMENTAL
Intervention: Lipid solution (1 ml/minute for 30 minutes)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Protein solution (4.18 J/ml)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Non-absorbable electrolyte solution containing polyethylene glycol
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 0.9% sodium chloride solution
Number of subjects: 28
Study: 7934538

Group type: EXPERIMENTAL
Intervention: Active treatment (pravastatin, nicotinic acid, cholestyramine, and gemfibrozil)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 79
Study: 3282033

Group type: EXPERIMENTAL
Intervention: Fluorouracil (5‐FU) 15 mg/kg/wk
Number of subjects: 141

Group type: COMPARATOR
Intervention: Fluorouracil (5‐FU) plus cisplatin (60 mg/m2 every 3 weeks)
Number of subjects: 141
Study: 30807835

Group type: EXPERIMENTAL
Intervention: ICG-based adjunctive antimicrobial photodynamic therapy (aPDT) with perio green® 0.1 mg/ml and diode laser at 808 nm (100 mW at 2 kHz)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Scaling and root planing (control group)
Number of subjects: 20
Study: 29972598

Group type: EXPERIMENTAL
Intervention: Experiential rumination
Number of subjects: 111

Group type: COMPARATOR
Intervention: Analytical rumination
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 111
Study: 27038632

Group type: EXPERIMENTAL
Intervention: Bilateral prefrontal transcranial direct current stimulation (tDCS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30
Study: 24846054

Group type: EXPERIMENTAL
Intervention: Neuropathic ulcers
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Neuro-ischemic ulcers
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Ischemic ulcers
Number of subjects: 73
Study: 21861125

Group type: EXPERIMENTAL
Intervention: SMARTp (small-incision access retroperitoneoscopic technique)
Number of subjects: 12

Group type: COMPARATOR
Intervention: SRTp (standard retroperitoneoscopic technique)
Number of subjects: 12
Study: 20849499

Group type: EXPERIMENTAL
Intervention: Clowns group (N = 25)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Premedication group (N = 25)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (N = 25)
Number of subjects: 75
Study: 18179308

Group type: EXPERIMENTAL
Intervention: Multi-Family Psychoeducation Groups (MFPGs), 8-session manual-driven treatment as an adjunct to current medications and psychotherapy.
Number of subjects: 165

Group type: COMPARATOR
Intervention: Wait-list condition (control group), n=87, randomized into a 1-year wait-list condition.
Number of subjects: 165
Study: 16306721

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia via an indwelling intrathecal catheter
Number of subjects: 60

Group type: COMPARATOR
Intervention: High-dose intravenous opioid
Number of subjects: 60
Study: 12407271

Group type: EXPERIMENTAL
Intervention: Intensive case management
Number of subjects: 225

Group type: COMPARATOR
Intervention: Standard case management
Number of subjects: 225
Study: 12799979

Group type: EXPERIMENTAL
Intervention: High self-efficacy and internal locus of control
Number of subjects: 56

Group type: COMPARATOR
Intervention: Low self-efficacy and high external locus of control
Number of subjects: 56
Study: 7993925

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation program (8-week ambulatory rehabilitation)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (NR-group) aged < or = 65
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (NR-group) aged > 65
Number of subjects: 32
Study: 3177586

Group type: EXPERIMENTAL
Intervention: Simultaneous vision bifocal contact lenses
Number of subjects: 10

Group type: COMPARATOR
Intervention: Monovision
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Bifocal stereopsis with best near over-refraction
Number of subjects: 10
Study: 30574864

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination (FDC) of gemigliptin 50 mg and metformin 500 mg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Loose combination of gemigliptin 50 mg and metformin 500 mg
Number of subjects: 28
Study: 7448102

Group type: EXPERIMENTAL
Intervention: Cervical extradural analgesia using 2% mepivacaine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thoracic extradural analgesia using 2% mepivacaine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both cervical and thoracic extradural analgesia
Number of subjects: 0
Study: 30664989

Group type: EXPERIMENTAL
Intervention: Atezolizumab (1200 mg intravenously every 3 weeks)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Chemotherapy (up to 6 cycles of topotecan or re-induction of initial chemotherapy)
Number of subjects: 73
Study: 28387891

Group type: EXPERIMENTAL
Intervention: Scopolamine butylbromide (intramuscular injection before operation)
Number of subjects: 142

Group type: COMPARATOR
Intervention: No preoperative intramuscular injection (control group)
Number of subjects: 142
Study: 26451155

Group type: EXPERIMENTAL
Intervention: Auricular Acupuncture (AA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham Auricular Acupuncture (SAA)
Number of subjects: 12
Study: 24102102

Group type: EXPERIMENTAL
Intervention: Telemedicine with a nonmydriatic camera
Number of subjects: 567

Group type: COMPARATOR
Intervention: Traditional surveillance with an eye care provider
Number of subjects: 567

Group type: EXPERIMENTAL
Intervention: Telemedicine group
Number of subjects: 567

Group type: EXPERIMENTAL
Intervention: Overall prevalence of diabetic retinopathy
Number of subjects: 567

Group type: EXPERIMENTAL
Intervention: Overall prevalence of macular edema
Number of subjects: 567
Study: 21896093

Group type: EXPERIMENTAL
Intervention: VFR children
Number of subjects: 698

Group type: COMPARATOR
Intervention: Non-VFR (tourist) children
Number of subjects: 698
Study: 19706089

Group type: EXPERIMENTAL
Intervention: pimecrolimus 1% cream plus microdermabrasion
Number of subjects: 65

Group type: COMPARATOR
Intervention: pimecrolimus 1% cream alone
Number of subjects: 65

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 65
Study: 18354887

Group type: EXPERIMENTAL
Intervention: Directional microphones
Number of subjects: 57

Group type: COMPARATOR
Intervention: Omni-directional microphones
Number of subjects: 57

Group type: COMPARATOR
Intervention: Toggle-switch equipped amplification
Number of subjects: 57

Group type: COMPARATOR
Intervention: Unaided group
Number of subjects: 57
Study: 15561650

Group type: EXPERIMENTAL
Intervention: MTZ/CTX 1 g once daily
Number of subjects: 70

Group type: COMPARATOR
Intervention: T/C 3.1 g every 6 hours
Number of subjects: 70
Study: 11557914

Group type: EXPERIMENTAL
Intervention: Reboxetine 2 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Reboxetine 4 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Reboxetine 6 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Reboxetine 6 mg with 200 mg ketoconazole
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9631989

Group type: EXPERIMENTAL
Intervention: Fluconazole 150 mg once weekly
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Fluconazole 300 mg once weekly
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Fluconazole 450 mg once weekly
Number of subjects: 362

Group type: COMPARATOR
Intervention: Placebo once weekly
Number of subjects: 362
Study: 7821469

Group type: EXPERIMENTAL
Intervention: Systemic anti-fibrinolytics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 3189489

Group type: EXPERIMENTAL
Intervention: Purposeful activity
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nonpurposeful activity
Number of subjects: 30
Study: 30727715

Group type: EXPERIMENTAL
Intervention: Information system intervention for nursing staff with individual performance feedback
Number of subjects: 977

Group type: COMPARATOR
Intervention: Control group with only global results feedback
Number of subjects: 977
Study: 28941842

Group type: EXPERIMENTAL
Intervention: Cold cabbage leaves
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Cold gel packs
Number of subjects: 227

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 227
Study: 26939316

Group type: EXPERIMENTAL
Intervention: Combined therapy of acupoint application of jieyu plaster and acupuncture
Number of subjects: 86

Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 86

Group type: COMPARATOR
Intervention: Acupoint application of jieyu plaster
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Combined therapy
Number of subjects: 86
Study: 24148164

Group type: EXPERIMENTAL
Intervention: Low-fat diet high in vegetables, fruits, and grains with intensive nutritional and behavior education
Number of subjects: 700

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 700
Study: 22105823

Group type: EXPERIMENTAL
Intervention: Decision aid (video and workbook) for discussing terminal prognosis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arm (how cancer pain can be controlled)
Number of subjects: 0
Study: 19749461

Group type: EXPERIMENTAL
Intervention: Cisplatin-based chemotherapy (exact dosage not specified)
Number of subjects: 57
Study: 16569254

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 290

Group type: COMPARATOR
Intervention: Bi-level Positive Airway Pressure (BiPAP)
Number of subjects: 290
Study: 12663292

Group type: EXPERIMENTAL
Intervention: Low-folate diet (120 microg/d) for 7 weeks
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Folate repletion with 400 microg/d for 7 weeks
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Folate repletion with 400 microg/d
Number of subjects: 33
Study: 10363732

Group type: EXPERIMENTAL
Intervention: Arthrotec 75 (diclofenac sodium 75 mg-misoprostol 200 microg) administered twice daily
Number of subjects: 1203

Group type: COMPARATOR
Intervention: nabumetone 1500 mg administered once daily
Number of subjects: 1203

Group type: EXPERIMENTAL
Intervention: Arthrotec 75
Number of subjects: 1203

Group type: COMPARATOR
Intervention: nabumetone
Number of subjects: 1203
Study: 8545563

Group type: EXPERIMENTAL
Intervention: Verapamil (V)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Enalapril (E)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Verapamil + Enalapril (V+E)
Number of subjects: 30
Study: 1952710

Group type: EXPERIMENTAL
Intervention: Tixocortol-neomycin combination (Pivalone-Neomycin nasal suspension)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Placebo (vehicle: N‐cetylpyridinium chloride, sodium chloride, sodium hydroxide solution, benzyl alcohol, purified water, monosodium phosphate)
Number of subjects: 211
Study: 6756484

Group type: EXPERIMENTAL
Intervention: Meditation training
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Meditation plus biofeedback‐aided relaxation
Number of subjects: 21

Group type: COMPARATOR
Intervention: No‐treatment control group
Number of subjects: 21
Study: 30888584

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (4800 IU/daily)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 29980805

Group type: COMPARATOR
Intervention: Open clavicular hook plate (cHP) implantation (GI)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Arthroscopically assisted double-suture-button (dDSB) implantation (GII)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (GIII)
Number of subjects: 73
Study: 26742487

Group type: EXPERIMENTAL
Intervention: Alternative immunosuppressive scheme (reduced cyclosporine dosage and substituted azathioprine for mycophenolate mofetil) in group 2
Number of subjects: 33

Group type: COMPARATOR
Intervention: Initial immunosuppressive scheme (azathioprine, cyclosporine, and steroids) in group 1
Number of subjects: 33
Study: 23681940

Group type: EXPERIMENTAL
Intervention: Valproic acid (VPA) 10–20 mg/kg/day
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 22506461

Group type: EXPERIMENTAL
Intervention: Discover cervical artificial disc replacement (CADR)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Anterior cervical decompression and fusion (ACDF)
Number of subjects: 24
Study: 20363843

Group type: COMPARATOR
Intervention: Methacholine challenge with cutoff <or= 4 mg/mL
Number of subjects: 120

Group type: COMPARATOR
Intervention: Methacholine challenge with cutoff <or= 16 mg/mL
Number of subjects: 120

Group type: COMPARATOR
Intervention: Eucapnic voluntary hyperpnea (EVH) test
Number of subjects: 120
Study: 18415773

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate 2 mL (Hyalgan 10.3 mg/mL)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Physiological saline 20 mL (distention)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Physiological saline 2 mL (placebo)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 251
Study: 15778423

Group type: EXPERIMENTAL
Intervention: Ranolazine with ketoconazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ranolazine with diltiazem
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ranolazine with simvastatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ranolazine in combination with diltiazem or simvastatin
Number of subjects: 0
Study: 12444880

Group type: EXPERIMENTAL
Intervention: Back Performance Scale (BPS)
Number of subjects: 288
Study: 10622010

Group type: EXPERIMENTAL
Intervention: Male patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Female patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GPs with a pessimistic view of depression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Most severe vignette
Number of subjects: 0
Study: 7540705

Group type: EXPERIMENTAL
Intervention: 20 mg beta-sitosterol three times per day
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 1781562

Group type: EXPERIMENTAL
Intervention: 50 mg CD p.o. on the evening before the operation, followed by 25 mg p.o. in the morning
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 2 mg F p.o. on the evening before the operation, followed by 1 mg p.o. in the morning
Number of subjects: 108

Group type: COMPARATOR
Intervention: No premedication
Number of subjects: 108
Study: 7004995

Group type: EXPERIMENTAL
Intervention: Corticosteroid therapy
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (no corticosteroid therapy)
Number of subjects: 77
Study: 31563396

Group type: EXPERIMENTAL
Intervention: Portable, accelerometer‐based hip navigation system
Number of subjects: 110

Group type: COMPARATOR
Intervention: Conventional surgical technique
Number of subjects: 110
Study: 31567988

Group type: EXPERIMENTAL
Intervention: Electroacupuncture treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham electroacupuncture treatment
Number of subjects: 36
Study: 28595610

Group type: EXPERIMENTAL
Intervention: Danggui‐Sayuk‐Ga‐Osuyu‐Saenggang‐tang (DSGOST)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 27117175

Group type: EXPERIMENTAL
Intervention: Study Group (SG, circulating the prime with 40 g albumin for 5 minutes before CPB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control Group (CG, receiving 40 g human albumin 5 minutes after the initiation of CPB)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Study Group (SG)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 60
Study: 24976416

Group type: EXPERIMENTAL
Intervention: Skimmed milk (500 mL/d) for 1 year
Number of subjects: 161

Group type: COMPARATOR
Intervention: Semi-skimmed milk (500 mL/d) for 1 year
Number of subjects: 161
Study: 21750118

Group type: EXPERIMENTAL
Intervention: Prophylactic adjuvant radiotherapy
Number of subjects: 83

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 83
Study: 19770669

Group type: EXPERIMENTAL
Intervention: Simvastatin/ezetimibe (10 mg simvastatin and 10 mg ezetimibe, once a day)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Simvastatin (80 mg, once a day)
Number of subjects: 23
Study: 16488405

Group type: EXPERIMENTAL
Intervention: Symbolic number magnitude processing (comparing Arabic digits)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Non-symbolic number magnitude processing (comparing collections)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Processing physical size of Arabic digits in a Stroop paradigm
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Comparison between MD and MD/RD children
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (normally achieving peers)
Number of subjects: 90
Study: 15574665

Group type: EXPERIMENTAL
Intervention: Groups with high entitativity presenting strong arguments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Groups with high entitativity presenting weak arguments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Groups with low entitativity presenting strong arguments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Groups with low entitativity presenting weak arguments
Number of subjects: 0
Study: 12119507

Group type: EXPERIMENTAL
Intervention: Oral prednisolone (PSL) >12.5 mg/day for at least 1 year
Number of subjects: 100

Group type: COMPARATOR
Intervention: Inhaled corticosteroid (BDP) alone
Number of subjects: 100
Study: 9987628

Group type: EXPERIMENTAL
Intervention: Dipivefrin 0.1%
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pilocarpine 2%
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline 0.9%
Number of subjects: 12
Study: 1443881

Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6